C M Bidwell & Associates Ltd. Makes New $39,000 Investment in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

C M Bidwell & Associates Ltd. acquired a new stake in Crescent Capital BDC, Inc. (NASDAQ:CCAP) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,015 shares of the company’s stock, valued at approximately $39,000.

A number of other hedge funds also recently made changes to their positions in the business. Condor Capital Management lifted its holdings in Crescent Capital BDC by 4.7% during the 4th quarter. Condor Capital Management now owns 284,055 shares of the company’s stock valued at $5,460,000 after purchasing an additional 12,852 shares during the last quarter. Kovitz Investment Group Partners LLC bought a new position in shares of Crescent Capital BDC in the third quarter valued at about $4,878,000. Franklin Resources Inc. lifted its stake in shares of Crescent Capital BDC by 35.2% during the 3rd quarter. Franklin Resources Inc. now owns 256,279 shares of the company’s stock worth $4,726,000 after buying an additional 66,713 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Crescent Capital BDC during the 4th quarter worth about $3,750,000. Finally, Denali Advisors LLC grew its stake in Crescent Capital BDC by 0.5% in the 4th quarter. Denali Advisors LLC now owns 183,783 shares of the company’s stock valued at $3,532,000 after buying an additional 855 shares during the last quarter. 49.46% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company reduced their price objective on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Friday, February 21st. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $19.20.

Crescent Capital BDC Trading Down 1.5 %

CCAP stock opened at $17.52 on Monday. Crescent Capital BDC, Inc. has a 52 week low of $16.81 and a 52 week high of $20.19. The company has a market capitalization of $649.33 million, a PE ratio of 8.80 and a beta of 0.82. The company’s 50-day simple moving average is $18.60 and its 200 day simple moving average is $18.79. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.32.

Crescent Capital BDC (NASDAQ:CCAP) last announced its earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. The business had revenue of $46.40 million for the quarter, compared to analyst estimates of $47.27 million. As a group, sell-side analysts anticipate that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current year.

Crescent Capital BDC Announces Dividend

The business also recently disclosed a dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were issued a $0.05 dividend. The ex-dividend date of this dividend was Friday, February 28th. Crescent Capital BDC’s dividend payout ratio is presently 84.42%.

Crescent Capital BDC Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.